Jacobs Levy Equity Management
OCUL icon

Jacobs Levy Equity Management’s Ocular Therapeutix OCUL Stock Holding History

Jacobs Levy Equity Management’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100,809
Closed -$418K – 1007
2022
Q3 		$418K Buy
+100,809
New +$418K ﹤0.01% 846
2022
Q1 		– Sell
-59,810
Closed -$417K – 1055
2021
Q4 		$417K Buy
+59,810
New +$417K ﹤0.01% 855